MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 29 - per page Previous page Next page
Order by
Novel glycated peptide and protein biomarkers for glycemic control, as well as a method to monitor glycemic control in diabetic patients More
A novel disposable contact lens biosensor for the continuous, non-invasive monitoring of physiological glucose for diabetic patients More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Methods for improving pancreatic endocrine function and delaying the onset of diabetes by enhancing beta cell function using ligands and/or regulators of Notch receptors More
This invention relates to methods for manipulating the immune system using small interfering RNA (siRNA). Potential applications include the development of organ storage/reperfusion solutions and treatments for a broad range of disease indications. More
The technology provides methods for diagnosis and treatment of conditions such as cancer, diabetes, or other conditions that are influenced by AM levels. More
The most desirable feature of this new compound is its ability to specifically inhibit O-GlcNAcase without targeting the related hexosaminidase A (HEX A) and hexoaminidase B (HEX B) enzymes. More
Provision of access to DNA samples of 16 common diseases to conduct association studies of specific single nucleotide polymorphisms (SNPs) and specific diseases More
Diabetes mellitus, a metabolic disease caused by deficiency of insulin, displays a higher or lower level of glucose concentration in blood than normal range(80-120mg/dL). More
Name of the inventor: Domenico Accili Problem or Unmet Need: Type II diabetes is a very complex disease involving many tissues and several key protein components, two of which are insulin receptor and the transcription factor FoxO1. Recently, FoxO1 was... More
Displaying 11..20 of 29 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us